🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in Germany / NCT04707651
Active, not recruiting Not applicable

Formula Diet Treatment for NASH Patients.

NCT04707651 · tracked via the Priya Life Science Germany tracker
Phase
Not applicable
Started
2021-01-18
Last updated
2026-06-04

Condition(s) studied

Steatohepatitis, Nonalcoholic

Investigational drug(s) / intervention(s)

Formula diet

Formula diet: Formula diet for 12 weeks

Study summary

Non-alcoholic steatohepatitis (NASH) - also called fatty liver - is medically a serious problem because the liver tissue becomes fatty and stiff, and inflammatory reactions occur. This increases the risk of liver fibrosis (= scarring of the liver), liver cirrhosis (= shrunken liver), a liver tumor or death. So far there is no recognized treatment option for this disease. However, there is evidence that a lifestyle change based on a reduced carbohydrate diet, more exercise and a significant weight loss that can improve NASH.

Eligibility

Sex
ALL
Min age
18 Years
Max age
99 Years
Healthy volunteers
No
Inclusion Criteria: * BMI\>25 kg/qm Exclusion Criteria: * history of drug or alcohol abuse * acute or chronic diseases (except type 2 diabetes) * pregnancy or breast feeding

Primary outcome measure(s)

Trial sites (2)

FacilityCityRegionStatus
Düsseldorf Catholic Hospital Group Düsseldorf Germany
Praxis Prof. Erhardt Wuppertal Germany

More West German Center of Diabetes and Health trials in Germany

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT04707651 on ClinicalTrials.gov ↗ ← All trials in Germany